Anxiety Medication Overview of Serax

Serax® is the brand name for the drug oxazepam, a benzodiazepine that has been in use since the 1960s.

Serax is used primarily for the treatment of anxiety, including anxiety in people with depression, and for the control of symptoms related to alcohol withdrawal. It is also sometimes prescribed off-label as a treatment for insomnia.

Potential for Dependence
As with all benzodiazepine medications, Serax has the potential for tolerance, dependence, and addiction. These effects are more likely when Serax is taken in high doses or over a prolonged period of time. In general, it is preferred to take benzodiazepines at the lowest effective dose and for the shortest amount of time possible. 10 to 15 mg taken 3 to 4 times per day is generally sufficient to treat mild to moderate anxiety, while more severe anxiety may require 15 to 30 mg several times per day.

Serax has a slower rate of absorption and slower onset of action than many other benzodiazepines and is also generally less toxic in large doses. It can, however, be dangerous in overdose, especially when taken in combination with alcohol. Fortunately, the effective dosages of Serax are well below dangerous levels. Common side effects of Serax include dizziness, drowsiness, headache, and memory problems.

Photo: Pexels

More Articles

When experiencing signs and symptoms of an anxiety disorder, as listed below, it is important to provide your doctor with as many specifics as...

A study from Deakin University that looked at 3,000 Australian adolescents has revealed that mental health in adolescents over time could be...

It is true that what we eat affects our mood but also true that our mood affects how our food is digested. Thoughts, beliefs, feelings, and our...

Much of our anxiety rests on assumptions that we have made. We assume the worst possible scenario will come true. We assume we know what others...

It’s pleasant to think that daydreaming, the time we spend musing or fantasizing while we are awake, makes us happier people. Then researchers...

SITEMAP